RegeneRx Biopharmaceuticals, Inc. (RGRX)
OTCMKTS · Delayed Price · Currency is USD
0.1610
0.00 (0.00%)
Oct 6, 2025, 8:00 PM EDT

RGRX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2022FY 2021FY 2020FY 2019FY 20182013 - 2017
Period Ending
Oct '25 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 2013 - 2017
02023591820
Upgrade
Market Cap Growth
-98.70%-13.19%-61.32%222.54%-7.52%6.66%
Upgrade
Enterprise Value
-2123601820
Upgrade
Last Close Price
0.1613.8916.0044.5014.0015.50
Upgrade
PS Ratio
3.16259.76299.21773.59239.84285.75
Upgrade
PB Ratio
-0.06-5.79-10.30-21.03-7.87-9.00
Upgrade
EV/Sales Ratio
-271.61293.91784.13237.60280.80
Upgrade
Debt / Equity Ratio
-0.40-0.42-0.52-0.36-0.31-0.02
Upgrade
Asset Turnover
0.130.090.080.120.160.27
Upgrade
Quick Ratio
0.060.532.871.072.640.75
Upgrade
Current Ratio
0.070.552.911.202.810.87
Upgrade
Return on Assets (ROA)
-148.50%-105.12%-90.41%-128.07%-158.88%-325.56%
Upgrade
Earnings Yield
-695.23%-8.66%-6.96%-2.56%-7.63%-10.01%
Upgrade
FCF Yield
--4.72%-4.31%-1.70%-6.18%-4.46%
Upgrade
Buyback Yield / Dilution
-1.74%-3.58%-3.93%-1.82%-8.49%0.18%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.